diabetestalk.net

Novolog Flexpen Dosage

What Is Novolog (insulin Aspart)?

What Is Novolog (insulin Aspart)?

Before you receive DARZALEX®, tell your healthcare provider about all of your medical conditions, including if you: have a history of breathing problems have had shingles (herpes zoster) are pregnant or plan to become pregnant. DARZALEX® may harm your unborn baby. Females who are able to become pregnant should use an effective method of birth control during treatment and for at least 3 months after your final dose of DARZALEX®. Talk to your healthcare provider about birth control methods that you can use during this time. are breastfeeding or plan to breastfeed. It is not known if DARZALEX® passes into your breast milk. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. DARZALEX® may be given alone or together with other medicines used to treat multiple myeloma. Your healthcare provider will decide the time between doses as well as how many treatments you will receive. Your healthcare provider will give you medicines before each dose of DARZALEX® and on the first day after each dose of DARZALEX® to help reduce the risk of infusion reactions. If you miss any appointments, call your healthcare provider as soon as possible to reschedule your appointment. Infusion reactions. Infusion reactions are common with DARZALEX® and can be severe. Your healthcare provider may temporarily stop your infusion or completely stop treatment with DARZALEX® if you have infusion reactions. Tell your healthcare provider right away if you get any of the following symptoms: shortness of breath or trouble breathing dizziness or lightheadedness (hypotension) cough wheezing throat tightness runny or stuffy nose headache itching nausea vomiting chills fever Changes in blood tests. DARZALEX Continue reading >>

Adjustable Dosing

Adjustable Dosing

Adjustable Dosing NovoLog® stays in step with your activities and mealtimes. Your health care provider will teach you how to adjust your NovoLog® dose to your eating, activity, and blood sugar levels. NovoLog® is designed to closely mimic your body's insulin patterns at mealtime. It is changed slightly so that it acts more quickly than regular human insulin. That is why it is called analog insulin. Keep in mind, you will need to eat a meal within 5 to 10 minutes after taking NovoLog®. For information on food labels and carb counting, click here. You and your diabetes care team will also have to see how your physical activity affects your insulin dosage and adjust it as needed. For example, when you are very physically active, you have to decide whether to eat more or take less insulin, since both physical activity and insulin decrease the amount of sugar in the blood. Checking your blood sugar often when you are physically active will help you figure out how each type of physical activity you do affects your blood sugar. NovoLog® Dosing Tool Your diabetes care team can help you learn how to fine-tune your NovoLog® doses throughout the day. While you are figuring out how to adjust your insulin dose, you will want to stay in close touch with your diabetes care team. If you are using NovoLog® FlexPen®, you can select doses from 1 to 60 units in 1-unit steps. NovoPen Echo® provides precise half-unit dosing from 0.5 units up to 30 units. It also records the insulin dose and time passed since the last injection. If you have type 2 diabetes, ask your diabetes care team if the NovoLog® Dosing Tool might be right for you. This tool was created to help with adding and adjusting your mealtime insulin dose. If you’ve been taking NovoLog® for a while and your A1C is not Continue reading >>

Starting With Novolog® Mix 70/30

Starting With Novolog® Mix 70/30

Do not share your NovoLog® Mix 70/30 FlexPen® with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them. Who should not take NovoLog® Mix 70/30? Do not take NovoLog® Mix 70/30 if: your blood sugar is too low (hypoglycemia) or you are allergic to any of its ingredients. Before taking NovoLog® Mix 70/30, tell your healthcare provider about all your medical conditions including, if you are: pregnant, planning to become pregnant, or are breastfeeding. taking new prescription or over-the-counter medicines, including supplements. Talk to your health care provider about how to manage low blood sugar. How should I take NovoLog® Mix 70/30? Read the Instructions for Use and take exactly as directed. NovoLog® Mix 70/30 starts acting fast. If you have type 1 diabetes, inject within 15 minutes before you eat a meal. If you have type 2 diabetes, inject within 15 minutes before or after starting your meal. Do not mix NovoLog® Mix 70/30 with other insulin products or use in an insulin pump. Know the type and strength of your insulin. Do not change your insulin type unless your health care provider tells you to. Check your blood sugar levels. Ask your health care provider what your blood sugar levels should be and when you should check them. Do not reuse or share your needles or syringes with other people. You may give other people a serious infection, or get a serious infection from them. What should I avoid while taking NovoLog® Mix 70/30? Do not drive or operate heavy machinery, until you know how NovoLog® Mix 70/30 affects you. Do not drink alcohol or use medicines that contain alcohol. What are the possible side effects of NovoLog® Mix 70/30? Serious side effects can lead to death, includin Continue reading >>

Novolog Flexpen 100 Unit/ml Subcutaneous

Novolog Flexpen 100 Unit/ml Subcutaneous

Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke.Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Read the Patient Information Leaflet provided by your pharmacist before you start using this medication and each time you get a refill. If you have any questions, ask your doctor, diabetes educator, or pharmacist.Learn all preparation and usage instructions from your health care professional and the product package.Before using, check this product visually for particles or discoloration. If either is present, do not use the insulin. Insulin aspart should be clear and colorless.Before injecting each dose, clean the injection site with rubbing alcohol. Change the injection site each time to lessen injury under the skin and to avoid developing problems under the skin (lipodystrophy). Insulin aspart may be injected in the stomach area, the thigh, or the back of the upper arm. Do not inject into skin that is red, swollen, or itchy. Do not inject cold insulin because this can be painful. The insulin container you are currently using can be kept at room temperature.Inject this medication under the skin as directed by your doctor. Some brands should be injected 5 to 10 minu Continue reading >>

What Are The Possible Side Effects Of Insulin Aspart (novolog, Novolog Flexpen, Novolog Penfill)?

What Are The Possible Side Effects Of Insulin Aspart (novolog, Novolog Flexpen, Novolog Penfill)?

NOVOLOG (insulin aspart) Injection DESCRIPTION NOVOLOG (insulin aspart injection) is a rapid-acting human insulin analog used to lower blood glucose. NOVOLOG is homologous with regular human insulin with the exception of a single substitution of the amino acid proline by aspartic acid in position B28, and is produced by recombinant DNA technology utilizing Saccharomyces cerevisiae (baker's yeast). Insulin aspart has the empirical formula C256H381N65O79S6 and a molecular weight of 5825.8. Figure 1: Structural formula of insulin aspart NOVOLOG is a sterile, aqueous, clear, and colorless solution, that contains insulin aspart 100 Units/mL, glycerin 16 mg/mL, phenol 1.50 mg/mL, metacresol 1.72 mg/mL, zinc 19.6 mcg/mL, disodium hydrogen phosphate dihydrate 1.25 mg/mL, sodium chloride 0.58 mg/mL and water for injection. NOVOLOG has a pH of 7.2-7.6. Hydrochloric acid 10% and/or sodium hydroxide 10% may be added to adjust pH. font size A A A 1 2 3 4 5 Next What is Type 2 Diabetes? The most common form of diabetes is type 2 diabetes, formerly called non-insulin dependent diabetes mellitus or "adult onset" diabetes, so-called because it typically develops in adults over age 35, though it can develop at any age. Type 2 diabetes is diagnosed more often in people who are overweight or obese, and who are not physically active. Type 2 diabetes is an illness in which the body does not process ingested sugars (glucose) properly. In type 2, the body usually produces some insulin, but not enough to allow the glucose into the cells for the body to use as energy. In addition, there can be insulin resistance, where it becomes difficult for the body to use the insulin produced. Type 2 diabetes is seen both in men and in women, though men have a slightly higher incidence of developing the dise Continue reading >>

What Is Insulin Aspart (novolog, Novolog Flexpen, Novolog Penfill)?

What Is Insulin Aspart (novolog, Novolog Flexpen, Novolog Penfill)?

A A A Medications and Drugs Brand Names: NovoLog, NovoLog FlexPen, NovoLog PenFill Generic Name: insulin aspart (Pronunciation: IN su lin AS part) What is the most important information I should know about insulin aspart (NovoLog, NovoLog FlexPen, NovoLog PenFill)? What should I discuss with my healthcare provider before using insulin aspart (NovoLog, NovoLog FlexPen, NovoLog PenFill)? What should I avoid while using insulin aspart (NovoLog, NovoLog FlexPen, NovoLog PenFill)? Insulin is a hormone that is produced in the body. It works by lowering levels of glucose (sugar) in the blood. Insulin aspart is a fast-acting form of insulin. Insulin aspart is used to treat type 1 (insulin-dependent) diabetes in adults and children who are at least 2 years old. Insulin aspart is usually given together with another long-acting insulin. Insulin aspart may also be used for other purposes not listed in this medication guide. What are the possible side effects of insulin aspart (NovoLog, NovoLog FlexPen, NovoLog PenFill)? Get emergency medical help if you have any of these signs of insulin allergy: itching skin rash over the entire body, wheezing, trouble breathing, fast heart rate, sweating, or feeling like you might pass out. Call your doctor if you have a serious side effect such as: swelling in your hands or feet; or low potassium (confusion, uneven heart rate, extreme thirst, increased urination, leg discomfort, muscle weakness or limp feeling). Hypoglycemia, or low blood sugar, is the most common side effect of insulin aspart. Symptoms of low blood sugar may include headache, nausea, hunger, confusion, drowsiness, weakness, dizziness, blurred vision, fast heartbeat, sweating, tremor, trouble concentrating, confusion, or seizure (convulsions). Watch for signs of low blood sugar. Continue reading >>

Novolog® (insulin Aspart Injection) 100 U/ml Indications And Usage

Novolog® (insulin Aspart Injection) 100 U/ml Indications And Usage

NovoLog® is contraindicated during episodes of hypoglycemia and in patients hypersensitive to NovoLog® or one of its excipients. Never Share a NovoLog® FlexPen, NovoLog® FlexTouch®, PenFill® Cartridge, or PenFill® Cartridge Device Between Patients, even if the needle is changed. Patients using NovoLog® vials must never share needles or syringes with another person. Sharing poses a risk for transmission of blood-borne pathogens. Changes in insulin strength, manufacturer, type, or method of administration may affect glycemic control and predispose to hypoglycemia or hyperglycemia. These changes should be made cautiously under close medical supervision and the frequency of blood glucose monitoring should be increased. NovoLog® (insulin aspart injection) 100 U/mL is an insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus. NovoLog® is contraindicated during episodes of hypoglycemia and in patients hypersensitive to NovoLog® or one of its excipients. Never Share a NovoLog® FlexPen, NovoLog® FlexTouch®, PenFill® Cartridge, or PenFill® Cartridge Device Between Patients, even if the needle is changed. Patients using NovoLog® vials must never share needles or syringes with another person. Sharing poses a risk for transmission of blood-borne pathogens. Changes in insulin strength, manufacturer, type, or method of administration may affect glycemic control and predispose to hypoglycemia or hyperglycemia. These changes should be made cautiously under close medical supervision and the frequency of blood glucose monitoring should be increased. Hypoglycemia is the most common adverse effect of insulin therapy. The timing of hypoglycemia may reflect the time-action profile of the insulin formulation. Glucose monitoring is re Continue reading >>

Dailymed - Novolog- Insulin Aspart Injection, Solution

Dailymed - Novolog- Insulin Aspart Injection, Solution

5.1 Never Share NOVOLOG FlexPen, NOVOLOG FlexTouch, PenFill Cartridge or PenFill Cartridge Device Between Patients NOVOLOG FlexPen, NOVOLOG FlexTouch, PenFill cartridge, and PenFill cartridge devices should never be shared between patients, even if the needle is changed. Patients using NOVOLOG vials must never share needles or syringes with another person. Sharing poses a risk for transmission of blood-borne pathogens. 5.2 Hyperglycemia or Hypoglycemia with Changes in Insulin Regimen Changes in insulin strength, manufacturer, type, or method of administration may affect glycemic control and predispose to hypoglycemia [See Warnings and Precautions (5.3)] or hyperglycemia. These changes should be made cautiously and only under close medical supervision, and the frequency of blood glucose monitoring should be increased. For patients with type 2 diabetes, dosage adjustments of concomitant anti-diabetic products may be needed. Hypoglycemia is the most common adverse effect of all insulin therapies, including NOVOLOG. Severe hypoglycemia can cause seizures, may lead to unconsciousness may be life threatening or cause death. Hypoglycemia can impair concentration ability and reaction time; this may place an individual and others at risk in situations where these abilities are important (e.g. driving or operating other machinery). Hypoglycemia can happen suddenly and symptoms may differ in each individual and change over time in the same individual. Symptomatic awareness of hypoglycemia may be less pronounced in patients with longstanding diabetes in patients with diabetic nerve disease, in patients using medications that block the sympathetic nervous system (e.g., beta-blockers) [see Drug Interactions (7) ], or in patients who experience recurrent hypoglycemia. The risk of hyp Continue reading >>

Selected Important Safety Information

Selected Important Safety Information

NovoLog® Mix 70/30 is contraindicated during episodes of hypoglycemia and in patients hypersensitive to NovoLog® Mix 70/30 or one of its excipients. Never Share a NovoLog® Mix 70/30 FlexPen® Between Patients, even if the needle is changed. Patients using NovoLog® Mix 70/30 vials must never share needles or syringes with another person. Sharing poses a risk for transmission of blood-borne pathogens. Changes in insulin strength, manufacturer, type, or method of administration may affect glycemic control and predispose to hypoglycemia or hyperglycemia. Changes should be made cautiously under close medical supervision and the frequency of blood glucose monitoring should be increased. NovoLog® Mix 70/30 (insulin aspart protamine and insulin aspart injectable suspension) 100 U/mL Indications and Usage NovoLog® Mix 70/30 (insulin aspart protamine and insulin aspart injectable suspension) 100 U/mL is a mixture of insulin aspart protamine and insulin aspart indicated to improve glycemic control in patients with diabetes mellitus. NovoLog® Mix 70/30 is not recommended for the treatment of diabetic ketoacidosis. The proportions of rapid-acting and long-acting insulins are fixed and do not allow for basal versus prandial dose adjustments. NovoLog® Mix 70/30 is contraindicated during episodes of hypoglycemia and in patients hypersensitive to NovoLog® Mix 70/30 or one of its excipients. Never Share a NovoLog® Mix 70/30 FlexPen® Between Patients, even if the needle is changed. Patients using NovoLog® Mix 70/30 vials must never share needles or syringes with another person. Sharing poses a risk for transmission of blood-borne pathogens. Changes in insulin strength, manufacturer, type, or method of administration may affect glycemic control and predispose to hypoglycemia or Continue reading >>

What Happens If I Miss A Dose (novolog, Novolog Flexpen, Novolog Penfill)?

What Happens If I Miss A Dose (novolog, Novolog Flexpen, Novolog Penfill)?

A A A insulin aspart (cont.) Since insulin aspart is used before meals, you may not be on a timed dosing schedule. Whenever you use insulin aspart, be sure to eat a meal within 5 to 10 minutes. Do not use extra insulin aspart to make up a missed dose. It is important to keep insulin aspart on hand at all times. Get your prescription refilled before you run out of medicine completely. What happens if I overdose (NovoLog, NovoLog FlexPen, NovoLog PenFill)? Seek emergency medical attention if you think you have used too much of this medicine. An insulin overdose can cause life-threatening hypoglycemia. Symptoms of severe hypoglycemia include extreme weakness, blurred vision, sweating, trouble speaking, tremors, stomach pain, confusion, seizure (convulsions), or coma. What should I avoid while using insulin aspart (NovoLog, NovoLog FlexPen, NovoLog PenFill)? Do not change the brand of insulin aspart or syringe you are using without first talking to your doctor or pharmacist. Avoid drinking alcohol. Your blood sugar may become dangerously low if you drink alcohol while using insulin aspart. Do not expose insulin aspart to high heat. Throw the medication away if it becomes hotter than 98 degrees F. What other drugs will affect insulin aspart (NovoLog, NovoLog FlexPen, NovoLog PenFill)? Using certain medicines can make it harder for you to tell when you have low blood sugar. Tell your doctor if you use any of the following: albuterol (Proventil, Ventolin); clonidine (Catapres); reserpine; guanethidine (Ismelin); or a beta-blocker such as atenolol (Tenormin), bisoprolol (Zebeta), labetalol (Normodyne, Trandate), metoprolol (Lopressor, Toprol), nadolol (Corgard), propranolol (Inderal, InnoPran), timolol (Blocadren), and others. There are many other medicines that can increase or Continue reading >>

Novolog Flexpen (subcutaneous)

Novolog Flexpen (subcutaneous)

IN-su-lin AS-part, ree-KOM-bi-nant Commonly used brand name(s) In the U.S. NovoLOG NovoLOG FlexPen NovoLOG PenFill Available Dosage Forms: Solution Therapeutic Class: Antidiabetic Pharmacologic Class: Insulin, Ultra Rapid Acting Uses For Novolog FlexPen Insulin aspart is a fast-acting type of insulin. Insulin is one of many hormones that help the body turn the food we eat into energy. This is done by using the glucose (sugar) in the blood as quick energy. Also, insulin helps us store energy that we can use later. When you have diabetes mellitus, your body cannot make enough or does not use insulin properly. So, you must take additional insulin to regulate your blood sugar and keep your body healthy. This is very important as too much sugar in your blood can be harmful to your health. Since insulin aspart acts faster than regular human insulin, you normally should use insulin aspart with a longer-acting insulin. This medicine is available only with your doctor's prescription. Before Using Novolog FlexPen In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered: Allergies Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully. Pediatric Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of insulin aspart in children. However, safety and efficacy of insulin aspart mix 50/50 and 70/30 in t Continue reading >>

Insulin Aspart, Recombinant (subcutaneous Route)

Insulin Aspart, Recombinant (subcutaneous Route)

Insulin aspart is a fast-acting type of insulin. Insulin is one of many hormones that help the body turn the food we eat into energy. This is done by using the glucose (sugar) in the blood as quick energy. Also, insulin helps us store energy that we can use later. When you have diabetes mellitus, your body cannot make enough or does not use insulin properly. So, you must take additional insulin to regulate your blood sugar and keep your body healthy. This is very important as too much sugar in your blood can be harmful to your health. Since insulin aspart acts faster than regular human insulin, you normally should use insulin aspart with a longer-acting insulin. This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Portions of this document last updated: March 01, 2017 Copyright 2018 Truven Health Analytics Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes. Continue reading >>

Insulin Aspart

Insulin Aspart

Insulin aspart is a fast-acting insulin analog marketed by Novo Nordisk as NovoLog/NovoRapid. It is a manufactured form of human insulin; where a single amino acid has been exchanged. This change helps the fast-acting insulin analog be absorbed quickly into the bloodstream. As a result, it starts working in minutes, which allows one to take insulin and eat right away. Fast-acting insulin analogs are considered to act similarly to the way insulin is released in people without diabetes mellitus. Novolog allows for a flexible dosing schedule, which allows patients to adjust their insulin according to any changes in their eating habits.[1] The safety and efficacy of insulin aspart (NovoLog/NovoRapid) in real-life clinical practice was evaluated in the A1chieve study. It was created through recombinant DNA technology so that the amino acid, B28, which is normally proline, is substituted with an aspartic acid residue. This analog has increased charge repulsion, which prevents the formation of hexamers, to create a faster-acting insulin. The sequence was inserted into the yeast genome, and the yeast expressed the insulin analog, which was then harvested from a bioreactor. According to JDRF, insulin aspart was approved for marketing in the United States by the Food and Drug Administration in June 2000.[citation needed] Chemical properties[edit] The components of insulin aspart are as follows: Metal ion – zinc (19.6 μg/mL) Buffer – disodium hydrogen phosphate dihydrate (1.25 mg/mL) Preservatives – m-cresol (1.72 mg/mL) and phenol (1.50 mg/mL) Isotonicity agents – glycerin (16 mg/mL) and sodium chloride (0.58 mg/mL). The pH of insulin aspart is 7.2–7.6.[2] Action time[edit] The onset of action is approximately 15 minutes, the peak action is reached in 45–90 minutes, Continue reading >>

Novolog, Novolog Flexpen, Novolog Penfill

Novolog, Novolog Flexpen, Novolog Penfill

What is NovoLog? NovoLog (insulin aspart)is a fast-acting insulin that starts to work about 15 minutes after injection, peaks in about 1 hour, and keeps working for 2 to 4 hours. Insulin is a hormone that works by lowering levels of glucose (sugar) in the blood. NovoLog is used to improve blood sugar control in adults and children with diabetes mellitus. This medicine is sometimes used together with a long-acting or intermediate-acting insulin. NovoLog is used to treat type 2 diabetes in adults. NovoLog is also used to treat type 1 diabetes in adults and children who are at least 2 years old. Important information NovoLog is a fast-acting insulin that begins to work very quickly. After using it, you should eat a meal within 5 to 10 minutes. Never share an injection pen or cartridge with another person. Sharing injection pens or cartridges can allow disease such as hepatitis or HIV to pass from one person to another. You should not use NovoLog if you are having an episode of hypoglycemia (low blood sugar). Before taking this medicine You should not use NovoLog if you are allergic to insulin aspart, or if you are having an episode of hypoglycemia (low blood sugar). NovoLog is not approved for use by anyone younger than 2 years old. This medicine should not be used to treat type 2 diabetes in a child of any age. To make sure NovoLog is safe for you, tell your doctor if you have: liver or kidney disease; or low levels of potassium in your blood (hypokalemia). Tell your doctor if you also take pioglitazone or rosiglitazone (sometimes contained in combinations with glimepiride or metformin). Taking certain oral diabetes medicines while you are using insulin may increase your risk of serious heart problems. Follow your doctor's instructions about using insulin if you are pregn Continue reading >>

Using Novolog® Flexpen®

Using Novolog® Flexpen®

Here is a quick guide to NovoLog® dosing using NovoLog® FlexPen®. Please read the full Instructions For Use that came with your FlexPen® carefully before using it. To see FlexPen® in action, watch the video below. FlexPen® Demo Video (7:05 min) This video shows you how to use your NovoLog® FlexPen®. NovoLog® FlexPen® should not be used by people who are blind or have severe visual problems without the help of a person who has good eyesight and who is trained to use NovoLog® FlexPen® the right way. Wash your hands. Check the label to make sure that you are using the right type of insulin. This is especially important if you take more than 1 type of insulin Pull off the pen cap. Wipe the rubber stopper with an alcohol swab Remove the protective tab from the needle and screw it onto your FlexPen® tightly. It is important that the needle is placed on straight Never place a disposable needle on your FlexPen® until you are ready to take your injection Pull off the big outer needle cap and then pull off the inner needle cap. Throw away the inner needle cap right away Always use a new needle for each injection Be careful not to bend or damage the needle before use To reduce the risk of needle stick, never put the inner needle cap back on the needle Small amounts of air may collect in the cartridge during normal use. To avoid injecting air and ensure proper dosing: Turn the dose selector to 2 units Hold your FlexPen® with the needle pointing up, and tap the cartridge gently a few times, which moves the air bubbles to the top Press the push-button all the way in until the dose selector is back to 0. A drop of insulin should appear at the tip of the needle If no drop appears, change the needle and repeat. If you still do not see a drop of insulin after 6 tries, do n Continue reading >>

More in insulin